Lưới hấp thụ Polyglactin so với Lưới Sinh học Hợp nhất Không Chéo cho Điều trị Phẫu thuật Hernia Vết mổ Bị nhiễm

Birolini C, de Miranda JS, Utiyama EM, Rasslan S, Birolini D. Active Staphylococcus aureus infection: Is it a contra-indication to the repair of complex hernias with synthetic mesh? A prospective observational study on the outcomes of synthetic mesh replacement, in patients with chronic mesh infection caused by Staphylococcus aureus. Int J Surg Lond Engl. 2016;28:56–62. Garner JS. CDC guideline for prevention of surgical wound infections, 1985. Supersedes guideline for prevention of surgical wound infections published in 1982. (Originally published in November 1985). Revised. Infect Control IC. 1986;7:193–200. Mathes T, Walgenbach M, Siegel R. Suture Versus Mesh Repair in Primary and Incisional Ventral Hernias: A Systematic Review and Meta-Analysis. World J Surg. 2016;40:826–835. Ventral Hernia Working Group, Breuing K, Butler CE, Ferzoco S, Franz M, Hultman CS, et al. Incisional ventral hernias: review of the literature and recommendations regarding the grading and technique of repair. Surgery. 2010;148:544–558. Ferzoco SJ. A systematic review of outcomes following repair of complex ventral incisional hernias with biologic mesh. Int Surg. 2013;98:399–408. Mariette C, Briez N, Denies F, Dervaux B, Duhamel A, Guilbert M, et al. Use of biological mesh versus standard wound care in infected incisional ventral hernias, the SIMBIOSE study: a study protocol for a randomized multicenter controlled trial. Trials. 2013;14:131. Choi JJ, Palaniappa NC, Dallas KB, Rudich TB, Colon MJ, Divino CM. Use of mesh during ventral hernia repair in clean-contaminated and contaminated cases: outcomes of 33,832 cases. Ann Surg. 2012;255:176–180. Tobias AM, Low DW. The use of a subfascial vicryl mesh buttress to aid in the closure of massive ventral hernias following damage-control laparotomy. Plast Reconstr Surg. 2003;112:766–776. Howdieshell TR, Proctor CD, Sternberg E, Cué JI, Mondy JS, Hawkins ML. Temporary abdominal closure followed by definitive abdominal wall reconstruction of the open abdomen. Am J Surg. 2004;188:301–306. Jernigan TW, Fabian TC, Croce MA, Moore N, Pritchard FE, Minard G, et al. Staged management of giant abdominal wall defects: acute and long-term results. Ann Surg. 2003;238:349–355; discussion 355-357. Hodgkinson JD, Maeda Y, Leo CA, Warusavitarne J, Vaizey CJ. Complex abdominal wall reconstruction in the setting of active infection and contamination: a systematic review of hernia and fistula recurrence rates. Colorectal Dis. 2017;19:319–330. Bondre IL, Holihan JL, Askenasy EP, Greenberg JA, Keith JN, Martindale RG, et al. Suture, synthetic, or biologic in contaminated ventral hernia repair. J Surg Res. 2016;200:488–494. Cobb WS, Warren JA, Ewing JA, Burnikel A, Merchant M, Carbonell AM. Open retromuscular mesh repair of complex incisional hernia: predictors of wound events and recurrence. J Am Coll Surg. 2015;220:606–613. Itani KM, Rosen M, Vargo D, Awad SS, Denoto G 3rd, Butler CE. Prospective study of single-stage repair of contaminated hernias using a biologic porcine tissue matrix: the RICH Study. Surgery. 2012;152:498–505. Rosen MJ, Krpata DM, Ermlich B, Blatnik JA. A 5-year clinical experience with single-staged repairs of infected and contaminated abdominal wall defects utilizing biologic mesh. Ann Surg. 2013;257:991–996. Sarmah BD, Holl-Allen RT. Porcine dermal collagen repair of incisional herniae. Br J Surg. 1984;71:524–525. Holl-Allen RT. Porcine dermal collagen repair of inguinal hernias. J R Coll Surg Edinb. 1984;29:154–157. Novitsky YW, Orenstein SB, Kreutzer DL. Comparative analysis of histopathologic responses to implanted porcine biologic meshes. Hernia. 2014;18:713–721. Ditzel M, Deerenberg EB, Grotenhuis N, Harlaar JJ, Monkhorst K, Bastiaansen-Jenniskens YM, et al. Biologic meshes are not superior to synthetic meshes in ventral hernia repair: an experimental study with long-term follow-up evaluation. Surg Endosc. 2013;27:3654–3662. Harth KC, Rosen MJ. Major complications associated with xenograft biologic mesh implantation in abdominal wall reconstruction. Surg Innov. 2009;16:324–329. Harth KC, Krpata DM, Chawla A, Blatnik JA, Halaweish I, Rosen MJ. Biologic mesh use practice patterns in abdominal wall reconstruction: a lack of consensus among surgeons. Hernia. 2013;17:13–20. Mariette C, Wind P, Micelli Lupinacci R, Tresallet C, Adham M, Arvieux C, et al. Practice patterns in complex ventral hernia repair and place of biological grafts: a national survey among French digestive academic surgeons. J Visc Surg. 2014;151:9–16. Ball JF, Sheena Y, Tarek Saleh DM, Forouhi P, Benyon SL, Irwin MS, et al. A direct comparison of porcine (StratticeTM) and bovine (Surgimend™) acellular dermal matrices in implant-based immediate breast reconstruction. J Plast Reconstr Aesthetic Surg. 2017;70:1076–1082. Huntington CR, Cox TC, Blair LJ, Schell S, Randolph D, Prasad T, et al. Biologic mesh in ventral hernia repair: Outcomes, recurrence, and charge analysis. Surgery. 2016;160:1517–1527. Kissane NA, Itani KMF. A decade of ventral incisional hernia repairs with biologic acellular dermal matrix: what have we learned? Plast Reconstr Surg. 2012;130:194S–202S. Renard Y, Lardière-Deguelte S, de Mestier L, Appere F, Colosio A, Kianmanesh R, et al. Management of large incisional hernias with loss of domain: A prospective series of patients prepared by progressive preoperative pneumoperitoneum. Surgery. 2016;160:426–435. Renard Y, de Mestier L, Cagniet A, Demichel N, Marchand C, Meffert JL, et al. Open retromuscular large mesh reconstruction of lumbar incisional hernias including the atrophic muscular area. Hernia. 2017;21(3):341–349. Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg. 2017;152:784–791. Abdelfatah MM, Rostambeigi N, Podgaetz E, Sarr MG. Long-term outcomes (>5-year follow-up) with porcine acellular dermal matrix (Permacol) in incisional hernias at risk for infection. Hernia. 2015;19:135–140. Sbitany H, Kwon E, Chern H, Finlayson E, Varma MG, Hansen SL. Outcomes Analysis of Biologic Mesh Use for Abdominal Wall Reconstruction in Clean-Contaminated and Contaminated Ventral Hernia Repair. Ann Plast Surg. 2015;75:201–204. Orenstein SB, Qiao Y, Klueh U, Kreutzer DL, Novitsky YW. Activation of human mononuclear cells by porcine biologic meshes in vitro. Hernia. 2010;14:401–407. Rosen MJ, Bauer JJ, Harmaty M, Carbonell AM, Cobb WS, Matthews B, et al. Multicenter, Prospective, Longitudinal Study of the Recurrence, Surgical Site Infection, and Quality of Life After Contaminated Ventral Hernia Repair Using Biosynthetic Absorbable Mesh: The COBRA Study. Ann Surg. 2017;265:205–211. Lee L, Mata J, Landry T, Khwaja KA, Vassiliou MC, Fried GM, et al. A systematic review of synthetic and biologic materials for abdominal wall reinforcement in contaminated fields. Surg Endosc. 2014;28:2531–2546. Majumder A, Winder JS, Wen Y, Pauli EM, Belyansky I, Novitsky YW. Comparative analysis of biologic versus synthetic mesh outcomes in contaminated hernia repairs. Surgery. 2016;160:828–838. Liang MK, Berger RL, Nguyen MT, Hicks SC, Li LT, Leong M. Outcomes with porcine acellular dermal matrix versus synthetic mesh and suture in complicated open ventral hernia repair. Surg Infect. 2014;15:506–512. Atema JJ, de Vries FEE, Boermeester MA. Systematic review and meta-analysis of the repair of potentially contaminated and contaminated abdominal wall defects. Am J Surg. 2016;212:982–995.e1. Carbonell AM, Criss CN, Cobb WS, Novitsky YW, Rosen MJ. Outcomes of synthetic mesh in contaminated ventral hernia repairs. J Am Coll Surg. 2013;217:991–998. Graf K, Ott E, Vonberg RP, Kuehn C, Schilling T, Haverich A. Surgical site infections-economic consequences for the health care system. Langenbecks Arch Surg. 2011;396:453–459. Stürmer T, Joshi M, Glynn RJ, Avorn J, Rothman KJ, Schneeweiss S. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol. 2006;59:437–447. Fischer JP, Basta MN, Krishnan NM, Wink JD, Kovach SJ. A Cost-Utility Assessment of Mesh Selection in Clean-Contaminated Ventral Hernia Repair. Plast Reconstr Surg. 2016;137:647–659. Sainfort A, Denis-Hallouard I, Aulagner G, Nuiry O, Armoiry X. Economic evaluation of medical devices not included in the French list of products and services qualifying for reimbursement: Example of biologic meshes.Ann Pharm Fr. 2016;75(5):398–407. Badylak SF. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl Immunol. 2004;12:367–377. Gruber-Blum S, Brand J, Keibl C, Fortelny RH, Redl H, Mayer F, et al. Abdominal wall reinforcement: biologic vs. degradable synthetic devices. Hernia. 2017;21:305–315. Söderbäck H, Mahteme H, Hellman P, Sandblom G. Prophylactic Resorbable Synthetic Mesh to Prevent Wound Dehiscence and Incisional Hernia in High High-risk Laparotomy: A Pilot Study of Using TIGR Matrix Mesh. Front Surg. 2016;3:28. Buell JF, Sigmon D, Ducoin C, Shapiro M, Teja N, Wynter E, et al. Initial Experience With Biologic Polymer Scaffold (Poly-4-hydroxybuturate) in Complex Abdominal Wall Reconstruction. Ann Surg. 2017;266:185–188.